Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00758953 · ClinicalTrials.gov registry record · Phase 2
Pain Associated With Endometriosis
A Phase 2 study, sponsored by Lumara Health.
- Completed
- Registry status
- Phase 2
- Development phase
- 66
- Enrollment target
NCT00758953 is a Phase 2 study that has completed, run by Lumara Health. The registered enrollment target is 66 participants.
The verdict
NCT00758953, a Phase 2 study, has completed, sponsored by Lumara Health.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 66 participants
- Enrollment target
Study Summary
This study will evaluate the efficacy and safety of an investigational medication compared with placebo in the treatment of pain associated with endometriosis.
Interventions
- DRUG Danazol Once Weekly
- DRUG Danazol Twice Weekly
- DRUG Placebo Once Weekly
- DRUG Placebo Twice Weekly
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2007-02 |
| Est. Completion | 2009-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00758953
The ClinicalTrials.gov registry entry for NCT00758953 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lumara Health, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Danazol Once Weekly is the first listed.
NCT00758953 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00758953 about?
NCT00758953 is a clinical study titled "Pain Associated With Endometriosis". This study will evaluate the efficacy and safety of an investigational medication compared with placebo in the treatment of pain associated with endometriosis.
What is the current status of trial NCT00758953?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 66 participants. The study started on 2007-02. Estimated completion is 2009-01.
What interventions are being tested in trial NCT00758953?
The interventions under investigation include: Danazol Once Weekly (DRUG), Danazol Twice Weekly (DRUG), Placebo Once Weekly (DRUG), Placebo Twice Weekly (DRUG).
Who is sponsoring clinical trial NCT00758953?
This trial is sponsored by Lumara Health, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.